Abstract
Neuroprotection is a therapeutic strategy directed at keeping retinal ganglion cells (RGCs) alive and functional. This article discusses three commonly asked questions about neuroprotection and attempts to answer them in the context of our current understanding of the pathophysiology of RGC loss in glaucomatous optic neuropathy.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Cytoprotection / drug effects
-
Glaucoma / drug therapy*
-
Glaucoma / physiopathology
-
Humans
-
Neuroprotective Agents / therapeutic use*
-
Optic Nerve Diseases / prevention & control
-
Retinal Ganglion Cells / drug effects*
-
Retinal Ganglion Cells / physiology